ID | PEPTIDE SEQUENCE | PEPTIDE NAME | LENGTH | CHIRALITY | LINEAR/CYCLIC | SOURCE | CATEGORY | N TERMINAL MODIFICATION | C TERMINAL MODIFICATION | CHEMICAL MODIFICATION | CARGO | PUBMED ID |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2071 | HHHHHHESGGGGSPGRRRRRRRRRRR | Foxp3-11R | 26 | L | Linear | Synthetic | NA | Conjugation with 6-histidine tag | NA | Linker (ESGGGGSPG) | Fluorophore (FITC) and protein (monoclonal antibodies) | 23541572 |
2072 | KFFKFFKFFK | CPP-PNA | 10 | L | Linear | Synthetic | NA | Free | Conjugation with nucleic acid | Nucleic acid is attached via an ethylene glyol linker | PNA | 23305655 |
2073 | KFFKFFKFFK | CPP-PNA | 10 | L | Linear | Synthetic | NA | Free | Conjugation with nucleic acid | Nucleic acid is attached via an ethylene glyol linker | PNA | 23305655 |
2074 | KFFKFFKFFK | CPP-PNA | 10 | L | Linear | Synthetic | NA | Free | Conjugation with nucleic acid | Nucleic acid is attached via an ethylene glyol linker | PNA | 23305655 |
2075 | KFFKFFKFFK | CPP-PNA | 10 | L | Linear | Synthetic | NA | Free | Conjugation with nucleic acid | Nucleic acid is attached via an ethylene glyol linker | PNA | 23305655 |
2076 | KFFKFFKFFK | CPP-PNA | 10 | L | Linear | Synthetic | NA | Free | Conjugation with nucleic acid | Nucleic acid is attached via an ethylene glyol linker | PNA | 23305655 |
2077 | KFFKFFKFFK | CPP-PNA | 10 | L | Linear | Synthetic | NA | Free | Conjugation with nucleic acid | Nucleic acid is attached via an ethylene glyol linker | PNA | 23305655 |
2078 | KFFKFFKFFK | CPP-PNA | 10 | L | Linear | Synthetic | NA | Free | Conjugation with nucleic acid | Nucleic acid is attached via an ethylene glyol linker | PNA | 23305655 |
2079 | KFFKFFKFFK | CPP-PNA | 10 | L | Linear | Synthetic | NA | Free | Conjugation with nucleic acid | Nucleic acid is attached via an ethylene glyol linker | PNA | 23305655 |
2080 | KFFKFFKFFK | CPP-PNA | 10 | L | Linear | Synthetic | NA | Free | Conjugation with nucleic acid | Nucleic acid is attached via an ethylene glyol linker | PNA | 23305655 |
2081 | CRGDKGPDC | iRGD-CDD | 9 | L | Linear | Synthetic | NA | Free | Free | NA | Fluorophore (Red fluorophor Dy550) | 23248118 |
2082 | ARRRAARAARRRAARAARRRAARAARRRAARA | 32 A-R | 32 | L | Linear | Synthetic | NA | Free | Free | NA | Nucleic acid (DNA labelled with FITC) | 23454086 |
2083 | AKKKAAKAAKKKAAKAAKKKAAKAAKKKAAKA | 32 A-K | 32 | L | Linear | Synthetic | NA | Free | Free | NA | Nucleic acid (DNA labelled with FITC) | 23454086 |
2084 | ARRRAARAARRRAARAARRRAARA | 24 A-R | 24 | L | Linear | Synthetic | NA | Free | Free | NA | Nucleic acid (DNA labelled with FITC) | 23454086 |
2085 | AKKKAAKAAKKKAAKAAKKKAAKA | 24 A-K | 24 | L | Linear | Synthetic | NA | Free | Free | NA | Nucleic acid (DNA labelled with FITC) | 23454086 |
2086 | ARRARAARRARAARRARAARRARAARRARA | 30 A-R | 30 | L | Linear | Synthetic | NA | Free | Free | NA | Nucleic acid (DNA labelled with FITC) | 23454086 |
2087 | AKKAKAAKKAKAAKKAKAAKKAKAAKKAKA | 30 A-K | 30 | L | Linear | Synthetic | NA | Free | Free | NA | Nucleic acid (DNA labelled with FITC) | 23454086 |
2088 | RARARARARARARARARARARARARARARARA | 32 RA | 32 | L | Linear | Synthetic | NA | Free | Free | NA | Nucleic acid (DNA labelled with FITC) | 23454086 |
2098 | CRGDK | CRGDK | 5 | L | Linear | Synthetic | NA | Free | Free | NA | Small molecule drug (Doxorubicin), DSPE- PEG2000 | 23634882 |
2099 | GLFEAIEGFIENGWEGMIDGWYGGGGrrrrrrrrrK | Peptide 599 | 36 | Mix | Linear | Synthetic | NA | Free | Biotinylation | Biotinylation at lysine residue | Nucleic acid (siRNA) | 24019920 |
2100 | rrrrrrrrr | 9R | 9 | D | Linear | Synthetic | NA | Biotinylation | Free | NA | Nucleic acid (siRNA) | 24019920 |
2101 | RRRRRRRR | GC/R8-Lip | 8 | L | Linear | Synthetic | NA | Stearylation | Free | NA | Protein [GC (-galactosylceramide), ovalbumin] | 23860186 |
2104 | RXRRXRILFQYRXRRXR | LB1_1 | 17 | Modified | Linear | Synthetic | Cationic | N-terminal alkyne is introduced using 4-pentynoic acid | Amidation | X, aminohexyl residue | PNA705 | 24105028 |
2105 | RXRRXRYQFLIRXRRXR | LB1_2 | 17 | Modified | Linear | Synthetic | Cationic | N-terminal alkyne is introduced using 4-pentynoic acid | Amidation | X, aminohexyl residue | PNA705 | 24105028 |
2106 | RXRRXRFLQIYRXRRXR | LB1_3 | 17 | Modified | Linear | Synthetic | Cationic | N-terminal alkyne is introduced using 4-pentynoic acid | Amidation | X, aminohexyl residue | PNA705 | 24105028 |
2107 | RXRRXRAAAAARXRRXR | LB1_4 | 17 | Modified | Linear | Synthetic | Cationic | N-terminal alkyne is introduced using 4-pentynoic acid | Amidation | X, aminohexyl residue | PNA705 | 24105028 |
2108 | RXRRXRIKFQYRXRRXR | LB1_5 | 17 | Modified | Linear | Synthetic | Cationic | N-terminal alkyne is introduced using 4-pentynoic acid | Amidation | X, aminohexyl residue | PNA705 | 24105028 |
2109 | RXRRXRIEFQYRXRRXR | LB1_6 | 17 | Modified | Linear | Synthetic | Cationic | N-terminal alkyne is introduced using 4-pentynoic acid | Amidation | X, aminohexyl residue | PNA705 | 24105028 |
2110 | RXRRXRIWFQYRXRRXR | LB1_7 | 17 | Modified | Linear | Synthetic | Cationic | N-terminal alkyne is introduced using 4-pentynoic acid | Amidation | X, aminohexyl residue | PNA705 | 24105028 |
2111 | RXRRXRIPFQYRXRRXR | LB1_8 | 17 | Modified | Linear | Synthetic | Cationic | N-terminal alkyne is introduced using 4-pentynoic acid | Amidation | X, aminohexyl residue | PNA705 | 24105028 |
2112 | KXRKXRILFQYKXRKXR | LB1_9 | 17 | Modified | Linear | Synthetic | Cationic | N-terminal alkyne is introduced using 4-pentynoic acid | Amidation | X, aminohexyl residue | PNA705 | 24105028 |
2113 | HXRHXRILFQYHXRHXR | LB1_10 | 17 | Modified | Linear | Synthetic | Cationic | N-terminal alkyne is introduced using 4-pentynoic acid | Amidation | X, aminohexyl residue | PNA705 | 24105028 |
2114 | SXRSXRILFQYSXRSXR | LB1_11 | 17 | Modified | Linear | Synthetic | Cationic | N-terminal alkyne is introduced using 4-pentynoic acid | Amidation | X, aminohexyl residue | PNA705 | 24105028 |
2115 | EXREXRILFQYEXREXR | LB1_12 | 17 | Modified | Linear | Synthetic | NA | N-terminal alkyne is introduced using 4-pentynoic acid | Amidation | X, aminohexyl residue | PNA705 | 24105028 |
2116 | RMKWKKILFQYRXRRXR | LB1_13 | 17 | Modified | Linear | Synthetic | Cationic | N-terminal alkyne is introduced using 4-pentynoic acid | Amidation | X, aminohexyl residue | PNA705 | 24105028 |
2117 | RXRRXRILFQYRMKWKK | LB1_14 | 17 | Modified | Linear | Synthetic | Cationic | N-terminal alkyne is introduced using 4-pentynoic acid | Amidation | X, aminohexyl residue | PNA705 | 24105028 |
2118 | KKWKMRILFQYRXRRXR | LB1_15 | 17 | Modified | Linear | Synthetic | Cationic | N-terminal alkyne is introduced using 4-pentynoic acid | Amidation | X, aminohexyl residue | PNA705 | 24105028 |
2119 | RXRRXRILFQYKKWKMR | LB1_16 | 17 | Modified | Linear | Synthetic | Cationic | N-terminal alkyne is introduced using 4-pentynoic acid | Amidation | X, aminohexyl residue | PNA705 | 24105028 |
2120 | LKlLKkLlkKLLkLL | [D]-K6L9 | 15 | Mix | Linear | Synthetic | NA | Stearylation | Amidation | NA | Nucleic acid (Plasmid) | 23727033 |
2122 | AGYLLGHINLHHLAHLHHILC | TH peptide | 21 | L | Linear | Synthetic | Cationic | Free | Free | NA | Nanoparticle (Liposomes) | 23891517 |
2123 | AGYLLGHINLHHLAHLHHIL | TH peptide | 20 | L | Linear | Synthetic | Cationic | Free | Amidation | NA | Nanoparticle (Liposomes) | 23891517 |
2124 | AGYLLGKINLKKLAKLLLIL | TK peptide | 20 | L | Linear | Synthetic | Cationic | Free | Amidation | NA | Nanoparticle (Liposomes) | 23891517 |
2125 | CHHRRRRHHC | CH2 R4 H2 C | 10 | L | Cyclic | Synthetic | NA | Stearylation | Free | NA | Nucleic aciud (siRNA) | 23911914 |
2127 | KWFKIQMQIRRWKNKR | PenetraMax | 16 | L | Linear | Synthetic | NA | Free | Free | NA | Protein (Insulin) | 24060698 |
2130 | RRRRRRRRRRR | poly-arginine | 11 | L | Linear | Synthetic | Cationic | Free | Conjugation with 6His-tag | NA | Protein (Oct-4 protein) | 25199543 |
2131 | RRRRRRRR | R8 | 8 | L | Linear | Synthetic | Cationic | Acetylation | Amidation | NA | Nucleic acid (GAPDH siRNA) | 25193363 |
2132 | RRRRRRRR | STR-R8 | 8 | L | Linear | Synthetic | Cationic | Stearylation | Amidation | NA | Nucleic acid (GAPDH siRNA) | 25193363 |
2133 | HHHHHHHHRRRRRRRR | STR-H8R8 | 16 | L | Linear | Synthetic | Cationic | Stearylation | Amidation | NA | Nucleic acid (GAPDH siRNA) | 25193363 |
2134 | RRRRRRRRRRRRRRR | R15 | 15 | L | Linear | Synthetic | Cationic | Acetylation | Amidation | NA | Nucleic acid (GAPDH siRNA) | 25193363 |
2135 | HHHHHHHHRRRRRRRRRRRRRRR | H8R15 | 23 | L | Linear | Synthetic | Cationic | Acetylation | Amidation | NA | Nucleic acid (GAPDH siRNA) | 25193363 |